Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act marked as EEA relevant by the EU and under scrutiny for incorporation into the EEA Agreement by Iceland, Liechtenstein and Norway Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Legal documents
Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Durchführungsbeschluss (EU) 2023/459 der Kommission vom 2. März 2023 zur Nichtgenehmigung von 2,2-Dibrom-2-cyanacetamid (DBNPA) als alten Wirkstoff zur Verwendung in Biozidprodukten der Produktart 4 gemäß der Verordnung (EU) Nr. 528/2012 des Europäischen Parlaments und des Rates
History
02.03.2023
Adoption date in the EU
23.03.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.